UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000048670
Receipt No. R000055446
Scientific Title Development of a visual field measurement application
Date of disclosure of the study information 2022/09/01
Last modified on 2022/08/15 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Development of a visual field measurement application
Acronym Development of a visual field measurement application
Scientific Title Development of a visual field measurement application
Scientific Title:Acronym Development of a visual field measurement application
Region
Japan

Condition
Condition Diseases that cause visual field defects
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To verify the feasibility of recording visual field measurements using an iPhone-mounted visual field measurement research application.
Basic objectives2 Others
Basic objectives -Others not applicable
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Detection of marriott blind spot
(Examining the accuracy of the marriott blind spot measurement)
Key secondary outcomes Age, gender, Ophthalmologic history, etc.
(Profiling by comparing measurement results by age, gender, ophthalmologic history, etc.)

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Other
Interventions/Control_1 Visual field measurement
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Japanese people over 20 years old who have downloaded research apps published on "TestFlight" or "Research Kit", Apple's framework for medical research
Key exclusion criteria No exclusion criteria
Target sample size 5600

Research contact person
Name of lead principal investigator
1st name Masahiro
Middle name
Last name Miyake
Organization Kyoto University Graduate School of Medicine
Division name Ophthalmology & Visual Sciences
Zip code 606-8507
Address 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, JAPAN
TEL 075-751-3250
Email miyakem@kuhp.kyoto-u.ac.jp

Public contact
Name of contact person
1st name Masahiro
Middle name
Last name Miyake
Organization Kyoto University Graduate School of Medicine
Division name Ophthalmology & Visual Sciences
Zip code 606-8507
Address 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, JAPAN
TEL 075-751-3250
Homepage URL
Email miyakem@kuhp.kyoto-u.ac.jp

Sponsor
Institute Kyoto University Graduate School of Medicine,Department of Ophthalmology & Visual Sciences
Institute
Department

Funding Source
Organization FINDEX Inc.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Kyoto University Graduate School and Faculty of Medicine, Ethics Committee
Address Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, JAPAN
Tel 075-753-4680
Email ethcom@kuhp.kyoto-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 09 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2022 Year 07 Month 22 Day
Date of IRB
Anticipated trial start date
2022 Year 09 Month 01 Day
Last follow-up date
2026 Year 08 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2022 Year 08 Month 15 Day
Last modified on
2022 Year 08 Month 15 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055446